SEMA3G Activators
SEMA3G activators encompass a range of chemical compounds that indirectly enhance the protein's functionality by influencing various signaling pathways and cellular processes. Forskolin, for instance, augments cAMP levels, indirectly facilitating SEMA3G's involvement in axonal guidance by activating PKA, which can modulate the cytoskeletal configuration essential for neuron navigation. Sphingosine-1-phosphate similarly influences cellular migration by modulating cytoskeletal dynamics through its receptors, processes in which SEMA3G is integral. Rolipram and IBMX both prevent the breakdown of cAMP, thus promoting PKA activity and potentially augmenting SEMA3G's guidance of neuronal growth cones. LY294002 and PD 98059 shift intracellular signaling by inhibiting PI3K and MEK, respectively, potentially enhancing SEMA3G's contribution to neuronal development and circuit formation.
Further refining neuron patterning, Y-27632 and NSC 23766 target the actin cytoskeleton by inhibiting ROCK and Rac1, which could support SEMA3G's role in axon guidance. CCG-1423's inhibition of the RhoA pathway and D4476's modulation of the Wnt signaling cascade may also indirectly amplify SEMA3G activity in neuronal growth cone dynamics. SB 203580 attenuates p38 MAPK activity, possibly tipping the balance of intracellular signaling in favor of SEMA3G-dependent pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP, which can activate protein kinase A (PKA). PKA phosphorylation can lead to changes in cytoskeletal configuration, influencing SEMA3G's role in axonal guidance. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts on its receptors to modulate the cytoskeletal organization and cellular migration, which are processes SEMA3G is known to be involved in. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase-4, leading to increased cAMP levels and activation of PKA, potentially enhancing SEMA3G mediated axonal guidance. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, raising cAMP levels and activating PKA, which could augment SEMA3G's involvement in neuronal patterning. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK, which may lead to cytoskeletal rearrangements that support SEMA3G's functions in guiding neuronal growth cones. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
CCG-1423 inhibits RhoA signaling pathway, which can lead to changes in the neuronal growth cone and enhance SEMA3G's axon guidance activity. | ||||||